Evidence-based clinical practice guideline for adult Still’s disease

Author:

Mimura Toshihide12,Kondo Yuya3,Ohta Akihide4,Iwamoto Masahiro5,Ota Akiko6,Okamoto Nami7,Kawaguchi Yasushi8,Kono Hajime9,Takasaki Yoshinari10,Takei Shuji11,Nishimoto Norihiro12,Fujimoto Manabu13,Asanuma Yu Funakubo1,Mimori Akio14,Okiyama Naoko13,Kaneko Shunta3,Takahashi Hiroyuki3,Yokosawa Masahiro3,Sumida Takayuki3

Affiliation:

1. Department of Rheumatology and Applied Immunology, Saitama Medical University, Saitama, Japan;

2. Center for Intractable Diseases, Saitama Medical University, Saitama, Japan;

3. Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;

4. Faculty of Medicine, Saga University, Saga, Japan;

5. Department of Internal Medicine, Division of Rheumatology/Clinical Immunology, Jichi Medical University, Tochigi, Japan;

6. Department of Social Medicine, Faculty of Medicine, Division of Public Health, Saitama Medical University, Saitama, Japan;

7. Department of Pediatrics, Osaka Medical College, Osaka, Japan;

8. Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan;

9. Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan;

10. Department of Rheumatology, Juntendo University Koshigaya Hospital, Saitama, Japan;

11. Faculty of Medicine, School of Health Sciences, Kagoshima University, Kagoshima, Japan;

12. Department of Molecular Regulation for Intractable Diseases, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;

13. Department of Dermatology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;

14. Department of Rheumatology, Iwate Prefectural Central Hospital, Iwate, Japan

Funder

Astellas Pharma

UCB Japan

Mitsubishi Tanabe

Takeda

Chugai Pharmaceutical Co.

Ayumi

Eisai

MSD

Novartis

Japan Blood Products Organization

Pfizer

Ono Pharma

Shionogi

Bristrol-Myyers Squibb

Maruho

Torii Phama

Kyowa Hakko Kirin

Ono

Health and Labour Sciences Research

Ministry of Health, Labour, and Welfare of Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3